Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'heparins' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 183 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Levieux, A; Rivera, V; Levieux, D
      Immunochemical control of the species origin of porcine crude heparin and detection of ovine and caprine materials

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    2. Samdani, S; Lachmann, E; Nagler, W
      Unilateral extremity swelling in female patients with cancer

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    3. Lopez-Sendon, J
      Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    4. Kelly, J; Rudd, A; Lewis, RR; Hunt, BJ
      Screening for subclinical deep-vein thrombosis

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    5. Kaiser, B; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Turton, EPL; Coughlin, PA; Berridge, DC; Mercer, KG
      A survey of deep venous thrombosis management by consultant vascular surgeons in the United Kingdom and Ireland

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    7. Grassegger, A; Fritsch, P; Reider, N
      Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: A prospective study

      DERMATOLOGIC SURGERY
    8. Porras, MC; Bonilla, BC; Gomez, EP; Ruiz, MG
      Dalteparin-induced extremity hematoma complicated by probable compartment syndrome

      ANNALS OF PHARMACOTHERAPY
    9. Porras, MC; Martin, MD; Ruiz, MG
      Dalteparin-induced retroperitoneal bleeding

      ANNALS OF PHARMACOTHERAPY
    10. Uflacker, R
      Interventional therapy for pulmonary embolism

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    11. Merli, GJ; Vanscoy, GJ; Rihn, TL; Groce, JB; McCormick, W
      Applying scientific criteria to therapeutic interchange: A balanced analysis of low-molecular-weight heparins

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    12. Cohen, M
      The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    13. Smith, BS; Gandhi, PJ
      Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins andglycoprotein IIb/IIIa receptor antagonists in renal failure

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    14. Tsukamoto, T; Hattori, M; Sakabe, M; Haginaka, J
      Determination of the molecular mass of new L-fucose-containing glycosaminoglycan and its distribution by high-performance gel-permeation chromatography with laser light-scattering detection

      ANALYTICAL SCIENCES
    15. Belmin, J; Medjahed, S; Trivalle, C; Lutzer, P
      Heparin use and risk patterns in geriatric patients: a one-day audit in France

      PRESSE MEDICALE
    16. Pastores, SM
      Acute respiratory failure in critically ill patients with cancer - Diagnosis and management

      CRITICAL CARE CLINICS
    17. Batchelor, WB; Mahaffey, KW; Berger, PB; Deutsch, E; Meier, S; Hasselblad, V; Fry, ET; Teirstein, PS; Ross, AM; Binanay, CA; Zidar, JP
      A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    18. Brown, DFM
      Treatment options for deep venous thrombosis

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    19. Momi, S; Nasimi, M; Colucci, M; Nenci, GP; Gresele, P
      Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition

      HAEMATOLOGICA
    20. Huber, K; Niessner, A; Niessner, H
      Low molecular weight heparins in acute coronary syndrome

      HERZ
    21. Franco, A
      Low molecular weight heparins and hemorrhagic risk in elderly patients

      REVUE DE MEDECINE INTERNE
    22. Pautas, E; Siguret, V; d'Urso, M; Laurent, M; Gaussem, P; Fevrier, M; Durand-Gasselin, B
      Monitoring of tinzaparin treatment at treatment dose of 10 days in elderlypatients

      REVUE DE MEDECINE INTERNE
    23. Figarella, I; Barbaud, A; Lecompte, T; De Maistre, E; Reichert-Penetrat, S; Schmutz, JL
      Cutaneous delayed hypersensitivity reactions to heparins and heparinoids.

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    24. Nader, HB; Pinhal, MAS; Bau, EC; Castro, RAB; Medeiros, GF; Chavante, SF; Leite, EL; Trindade, ES; Shinjo, SK; Rocha, HAO; Tersariol, ILS; Mendes, A; Dietrich, CP
      Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    25. Varki, A; Varki, NM
      P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    26. Guerrini, M; Bisio, A; Torri, G
      Combined quantitative H-1 and C-13 nuclear magnetic resonance spectroscopyfor characterization of heparin preparations

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    27. Riess, H; Loew, A; Himmelreich, G
      Secondary osteoporosis induced by anticoagulant drugs?

      ORTHOPADE
    28. Goldhaber, SZ
      Unsolved issues in the treatment of pulmonary embolism

      THROMBOSIS RESEARCH
    29. Hofmann, S; Knoefler, R; Lorenz, N; Siegert, G; Wendisch, J; Mueller, D; Taut-Sack, H; Dinger, J; Kabus, M
      Clinical experiences with low-molecular weight heparins in pediatric patients

      THROMBOSIS RESEARCH
    30. Ahmad, S; Jeske, WP; Ma, Q; Walenga, JM; Fareed, J
      Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist

      THROMBOSIS RESEARCH
    31. Klein-Weigel, P; Fraedrich, G
      Conservative treatment of acute deep vein thrombosis of the lower extremity

      ZENTRALBLATT FUR CHIRURGIE
    32. Mary, V; Wahl, F; Uzan, A; Stutzmann, JM
      Enoxaparin in experimental stroke - Neuroprotection and therapeutic windowof opportunity

      STROKE
    33. Kelly, J; Rudd, A; Lewis, R; Hunt, BJ
      Venous thromboembolism after acute stroke

      STROKE
    34. Smorenburg, SM; Van Noorden, CJF
      The complex effects of heparins on cancer progression and metastasis in experimental studies

      PHARMACOLOGICAL REVIEWS
    35. Spandorfer, J
      The management of anticoagulation before and after procedures

      MEDICAL CLINICS OF NORTH AMERICA
    36. Liaw, PCY; Becker, DL; Stafford, AR; Fredenburgh, JC; Weitz, JI
      Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    37. Taraktchoglou, M; Pacey, AA; Turnbull, JE; Eley, A
      Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent onhost cell heparan sulfate

      INFECTION AND IMMUNITY
    38. Hamel, E; Pacouret, G; Vincentelli, D; Forissier, JF; Peycher, P; Pottier, JM; Charbonnier, B
      Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation - Results from a 128-patient monocenter registry

      CHEST
    39. Lee, JB; Srisomporn, P; Hayashi, K; Tanaka, T; Sankawa, U; Hayashi, T
      Effects of structural modification of calcium spirulan, a sulfated polysaccharide from Spirulina platensis, on antiviral activity

      CHEMICAL & PHARMACEUTICAL BULLETIN
    40. Kaaja, R; Pettila, V; Leinonen, P; Ylikorkala, O
      Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins

      BRITISH JOURNAL OF HAEMATOLOGY
    41. Bisio, A; De Ambrosi, L; Gonella, S; Guerrini, M; Guglieri, S; Maggia, G; Torri, G
      Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    42. Ruiz-Calero, V; Puignou, L; Diez, M; Galceran, MT
      Determination of free and total sulfate and phosphate in glycosaminoglycans by column-switching high-performance size-exclusion and ion chromatography and single-column ion chromatography

      ANALYST
    43. Kereiakes, DJ; Kleiman, NS; Fry, E; Mwawasi, G; Lengerich, R; Maresh, K; Burkert, ML; Aquilina, JW; DeLoof, M; Broderick, TM; Shimshak, TM
      Dalteparin in combination with abciximab during percutaneous coronary intervention

      AMERICAN HEART JOURNAL
    44. Holmes, SJ; Yale, SH; Mazza, JJ
      Rectus sheath hematoma as a cause of acute abdominal pain

      AMERICAN FAMILY PHYSICIAN
    45. von Tempelhoff, GF; Nieman, F; Heilmann, L; Hommel, G
      Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    46. Wallentin, L
      Low molecular weight heparin in unstable coronary artery disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    47. Ahsan, A; Jeske, W; Wolf, H; Fareed, J
      Isoamyl nitrite depolymerized heparin as a universal calibrator for heparins and low molecular weight heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    48. Leitienne, P; Fouque, D; Rigal, D; Adeleine, P; Trzeciak, MC; Laville, M
      Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    49. Planes, A
      Prevention of deep vein thrombosis after hip replacement - Reply

      THROMBOSIS AND HAEMOSTASIS
    50. Turpie, AGG
      Can we differentiate the low-molecular-weight heparins?

      CLINICAL CARDIOLOGY
    51. Wallentin, L
      Long-term management - The way forward?

      CLINICAL CARDIOLOGY
    52. Enrique, E; Alijotas, J; Cistero, A; san Miguel, MM; Bartra, J; Tresserra, F
      Patch-test positivity in cutaneous reactions to enoxaparin

      CONTACT DERMATITIS
    53. Samama, MM; Gerotziafas, GT
      Comparative pharmacokinetics of LMWHs

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    54. Breddin, HK
      Prophylaxis and treatment of deep-vein thrombosis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    55. Zacharski, LR; Ornstein, DL; Mamourian, AC
      Low-molecular-weight heparin and cancer

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    56. Lobato-Mendizabal, E; Majluf-Cruz, A
      Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins

      REVISTA DE INVESTIGACION CLINICA
    57. Yee, JYV; Duffull, SB
      The effect of body weight on dalteparin pharmacokinetics - A preliminary study

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    58. Nugent, MA
      Heparin sequencing brings structure to the function of complex oligosaccharides

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    59. Borja, J; Olivella, P
      Low molecular weigh heparin in the treatment of acute coronary syndromes without ST elevation: unstable angina and non Q wave myocardial infaction

      MEDICINA CLINICA
    60. Chaves, CJ; Caplan, LR
      Heparin and oral anticoagulants in the treatment of brain ischemia

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    61. Muller, M; Buchi, L; Woodtli, K; Haeberli, A; Beer, JH
      Preparation and characterization of 'heparinocytes': erythrocytes with covalently bound low molecular weight heparin

      FEBS LETTERS
    62. Makris, M; Hough, RE; Kitchen, S
      Poor reversal of low molecular weight heparin by protamine

      BRITISH JOURNAL OF HAEMATOLOGY
    63. Fabris, F; Ahmad, S; Cella, G; Jeske, WP; Walenga, JM; Fareed, J
      Pathophysiology of heparin-induced thrombocytopenia clinical and diagnostic implications - A review

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    64. Granger, CB
      Strategies at patient care in acute coronary syndromes: Rationale for the Global Registry of Acute Coronary Events (GRACE) Registry

      AMERICAN JOURNAL OF CARDIOLOGY
    65. Ahmad, S; Jeske, WP; Walenga, JM; Hoppensteadt, DA; Wood, JJ; Herbert, JM; Messmore, HL; Fareed, J
      Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    66. Mammen, EF
      Low molecular weight heparins and heparin-induced thrombocytopenia

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    67. Peek, GJ; Firmin, RK
      The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation

      ASAIO JOURNAL
    68. Imada, K; Takahashi, Y; Hosaka, Y; Adachi, T; Niina, H; Mochizuki, H
      ATIII-independence of anticoagulant effect of human urinary soluble thrombomodulin

      BLOOD COAGULATION & FIBRINOLYSIS
    69. Haas, S
      Limitations of established antithrombotic strategies

      BLOOD COAGULATION & FIBRINOLYSIS
    70. Agnelli, G; Taliani, MR; Verso, M
      Building effective prophylaxis of deep vein thrombosis in the outpatient setting

      BLOOD COAGULATION & FIBRINOLYSIS
    71. Lassen, MR; Borris, LC; Backs, S; Kaltoft-Sorensen, M; Coff-Ganes, H; Jeppesen, E
      Clinical limitations of risk assessment models

      BLOOD COAGULATION & FIBRINOLYSIS
    72. Gallus, AS
      Applying risk assessment models in orthopaedic surgery: overview of our clinical experience

      BLOOD COAGULATION & FIBRINOLYSIS
    73. Ageno, W
      Applying risk assessment models in general surgery: overview of our clinical experience

      BLOOD COAGULATION & FIBRINOLYSIS
    74. Samama, MM
      Applying risk assessment models in general surgery: effective risk stratification

      BLOOD COAGULATION & FIBRINOLYSIS
    75. Piovella, F; Barone, M
      Long-term management of deep vein thrombosis

      BLOOD COAGULATION & FIBRINOLYSIS
    76. Duteil, S; Gareil, P; Girault, S; Mallet, A; Feve, C; Siret, L
      Identification of heparin oligosaccharides by direct coupling of capillaryelectrophoresis/ionspray-mass spectrometry

      RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    77. Koscielny, J; Latza, R; Kiesewetter, H
      Thrombosis prophylaxis and outpatient medication

      PHLEBOLOGIE
    78. Saltissi, D; Morgan, C; Westhuyzen, J; Healy, H
      Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    79. Vanscoy, GJ
      Outpatient management of venous thromboembolism

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    80. Bauld, DL; Kovacs, MJ
      Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    81. Grossman, C; McPherson, S
      Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis

      AMERICAN JOURNAL OF ROENTGENOLOGY
    82. Beguin, S; Welzel, D; Al Dieri, R; Hemker, HC
      Conjectures and refutations on the mode of action of heparins - The limited importance of anti-factor Xa activity as a pharmaceutical mechanism and ayardstick for therapy

      HAEMOSTASIS
    83. Wallentin, L
      Low-molecular-weight heparins in coronary thrombosis: Today and tomorrow

      HAEMOSTASIS
    84. van der Woude, FJ
      Heparins in diabetic microangiopathy: Rationale and preliminary clinical results

      HAEMOSTASIS
    85. Conard, J; Horellou, MH; Samama, MM; Samama, RM
      Management of pregnancy in women with thrombophilia

      HAEMOSTASIS
    86. Roy, S; Brosstad, F; Sakariassen, KS
      Selective thrombolysis in acute deep vein thrombosis: Evaluation of adjuvant therapy in vivo

      CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
    87. Finotti, P; Pagetta, A; Corvaja, C
      Role of reducing terminals in unfractionated and low-molecular-mass heparins in causing free radical generation and loss of structure and activity oftrypsin

      INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
    88. Gouin-Thibault, I; Samama, MM
      Laboratory diagnosis of the thrombophilic state in cancer patients

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    89. Lamy, O; Cornuz, J; Yersin, B
      Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis: a systematic review

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    90. Barsotti, G; Cupisti, A; Gervasi, GB; Bartoli, C; Barsotti, M; Pasquariello, A; Moriconi, L; Giovannetti, S
      Effects of oral administration of heparan sulphate in the rat remnant kidney model

      NEPHRON
    91. Ta, TV; Takano, R; Kamei, K; Xu, XY; Kariya, Y; Yoshida, K; Hara, S
      Fructose 1,6-bisphosphate aldolase is a heparin-binding protein

      JOURNAL OF BIOCHEMISTRY
    92. Fletcher, JP; McLellan, D; Cade, J; Fisher, C; Gibbs, H; Stacey, M; Vedig, A
      Prevention of venous thrombo-embolism

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY
    93. Ramamurthy, N; Baliga, N; Wakefield, TW; Andrews, PC; Yang, VC; Meyerhoff, ME
      Determination of low-molecular-weight heparins and their binding to protamine and a protamine analog using polyion-sensitive membrane electrodes

      ANALYTICAL BIOCHEMISTRY
    94. Spandorfer, JM; Lynch, S; Weitz, HH; Fertel, S; Merli, GJ
      Use of Enoxaparin for the chronically anticoagulated patient before and after procedures

      AMERICAN JOURNAL OF CARDIOLOGY
    95. STREKERUD FG; ABILDGAARD U
      HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN PROLONG PROTHROMBIN TIMES INPATIENTS ON WARFARIN TREATMENT

      Clinical and applied thrombosis/hemostasis
    96. QUINN DA; DU HK; THOMPSON BT; HALES CA
      AMILORIDE ANALOGS INHIBIT CHRONIC HYPOXIC PULMONARY-HYPERTENSION

      American journal of respiratory and critical care medicine
    97. MARTINEAU P; TAWIL N
      LOW-MOLECULAR-WEIGHT HEPARINS IN THE TREATMENT OF DEEP-VEIN THROMBOSIS

      The Annals of pharmacotherapy
    98. SANTAMARIA A; ROMANI J; SOUTO JC; LOPEZ A; MATEO J; FONTCUBERTA J
      SKIN NECROSIS AT THE INJECTION SITE INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN - CASE-REPORT AND REVIEW

      Dermatology
    99. KAUW FHW; CLEOPHAS TJM; KALMANSOHN RB
      LOW-MOLECULAR-WEIGHT HEPARINS BETTER THAN UNFRACTIONATED HEPARIN IN UNSTABLE CORONARY-ARTERY DISEASE - UNSTABLE ANGINA-PECTORIS NON-Q-WAVE INFARCTION A PARTLY OUTPATIENT-CLINIC CONDITION

      International journal of clinical pharmacology and therapeutics
    100. LIPSCOMBE RJ; NAKHOUL AM; SANDERSON CJ; COOMBE DR
      INTERLEUKIN-5 BINDS TO HEPARIN HEPARAN-SULFATE - A MODEL FOR AN INTERACTION WITH EXTRACELLULAR-MATRIX

      Journal of leukocyte biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 14:16:28